Modificare „ABEONA THERAPEUTICS INC.”

Pagina dedicata companiei ABEONA THERAPEUTICS INC. listata cu simbolurile US.ABEO, US.ABEOc

==Descriere companie==
Abeona Therapeutics Inc.  (https://abeonatherapeutics.com/) is a clinical-stage biopharmaceutical company that develops gene and cell therapies for life-threatening rare genetic diseases. The Company’s lead clinical programs consist of EB-101, which is an autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa (RDEB), ABO-102, which is an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A (MPS IIIA), and ABO-101, which is an AAV-based gene therapy for Sanfilippo syndrome type B (MPS IIIB). It is focused on to develop additional AAV-based gene therapies designed to treat ophthalmic and other diseases and AAV-based gene therapies using the AIM capsid platform that has a license from the University of North Carolina at Chapel Hill and internal AAV vector research programs.

==Grafic actiuni companie==
<iframe key="tradeville" path="graficSimbol/US.ABEO" />
<iframe key="tradeville" path="graficSimbol/US.ABEOc" />

==Ultimele stiri despre ABEONA THERAPEUTICS INC. (US.ABEO)==
<dynamicpagelist>
category=US.ABEO
count=10
order=descending
addfirstcategorydate=false
</dynamicpagelist>
==Ultimele stiri despre ABEONA THERAPEUTICS INC. (US.ABEOc)==
<dynamicpagelist>
category=US.ABEOc
count=10
order=descending
addfirstcategorydate=false
</dynamicpagelist>

[[Categorie:US.ABEO]][[Categorie:US.ABEOc]][[Categorie:Stiri despre companii]]